-
FDA limits usage of Lilly and Regeneron’s monoclonal antibodies for Covid-19
Pharmaceutical-Technology
January 26, 2022
The move comes after data showed these therapies are highly unlikely to be active against the Omicron variant.
-
New study suggests two paths toward ‘super immunity’ to COVID-19
WorldPharmaNews
January 26, 2022
New laboratory research from Oregon Health & Science University reveals more than one path toward robust immunity from COVID-19.
-
EU Eases COVID-19 Travel Rules Within the Bloc for Fully Vaccinated
drugs.com
January 26, 2022
European Union residents should be able to move freely between the 27 member nations if they have been vaccinated in the past
-
More Than 1 Million U.S. Children Diagnosed With COVID-19 in Single Week
drugs.com
January 26, 2022
More than 1.1 million American children were diagnosed with COVID-19 during the week ending Jan. 20, new data show. That is 17 percent...
-
Omicron relief: Pfizer and BioNTech initiate study into targeted vaccine
pharmatimes
January 26, 2022
COVID-19 vaccine luminaries Pfizer and BioNTech study will examine data from the current booster and consider need for specific Omicron jab。
-
~7 Percent of Lung Transplants Due to COVID-19 Respiratory Failure
drugs.com
January 26, 2022
From August 2020 through September 2021, about 7 percent of lung transplantations were performed in patients with COVID-19-related...
-
Booster Shots More Effective During Omicron Emergence Period
drugs.com
January 26, 2022
Booster doses seem effective for the severe acute respiratory syndrome coronavirus 2 omicron variant..
-
Biden Administration Withdraws Vaccine Mandate for Large Employers
drugs.com
January 26, 2022
The Biden administration on Tuesday withdrew an emergency COVID-19 vaccine-or-test mandate...
-
Cellvera Receives $20M Order for COVID-19 Oral Antiviral Avigan
contractpharma
January 25, 2022
Favipiravir is a broad-spectrum oral antiviral drug that targets COVID-19 and 11 other infectious diseases.
-
Pfizer Begins Testing COVID-19 Vaccine Targeted to Omicron
drugs.com
January 25, 2022
Pfizer Inc. announced Tuesday that it has launched a trial that will compare its existing COVID-19 vaccine against...